Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,240
Closed -$2.21M 307
2019
Q3
$2.21M Sell
22,240
-144
-0.6% -$13.7K 0.01% 215
2019
Q2
$2.07M Buy
22,384
+647
+3% +$61.4K 0.01% 208
2019
Q1
$2.05M Sell
21,737
-88,765
-80% -$7.76M 0.02% 209
2018
Q4
$7.08M Sell
110,502
-24,917
-18% -$1.84M 0.04% 130
2018
Q3
$12.1M Sell
135,419
-7,706
-5% -$681K 0.06% 98
2018
Q2
$11.4M Sell
143,125
-88,282
-38% -$7.33M 0.06% 96
2018
Q1
$20.6M Buy
231,407
+66,975
+41% +$6.43M 0.12% 64
2017
Q4
$17.2M Buy
164,432
+19,299
+13% +$2.18M 0.1% 75
2017
Q3
$21.2M Buy
145,133
+5,289
+4% +$720K 0.13% 65
2017
Q2
$18.2M Buy
+139,844
New +$17.1M 0.12% 69

Other funds holding CELG

TIAA FSB's CELG Position: Q4 2019 in Review

TIAA FSB sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,240 shares — an estimated $2.21M sold.

TIAA FSB first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $21.2M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • TIAA FSB reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • TIAA FSB sold 22,240 Celgene Corp shares in Q4 2019, an estimated $2.21M.
  • TIAA FSB first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
  • TIAA FSB's Celgene Corp position peaked at $21.2M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on TIAA FSB's 13F filing for Q4 2019, filed 13 Jan 2020.